Policies

AI Tools Usage Policy
As a multidisciplinary journal dedicated to bridging experimental biology, computational modeling, and translational biomedical applications, the Journal of Integrated Biotechnology Research (JIBR) recognizes the rapid integration of Generative Artificial Intelligence (AI) and AI-assisted technologies in scientific writing and data processing. This policy establishes the ethical framework and disclosure requirements for authors utilizing these tools during the research and manuscript preparation process.

1. Authorship and Accountability
- AI cannot be listed as an author: AI tools (such as ChatGPT, DeepMind, or similar large language models) do not qualify for authorship. They cannot assume legal liability, manage competing interests, sign copyright agreements, or take intellectual ownership of the scientific findings.
- Human Responsibility: The submitting authors retain full, irrevocable responsibility for the scientific rigor, accuracy, originality, and integrity of the manuscript. Authors must critically review and verify all AI-generated suggestions, ensuring that all biological data, statistical outputs, and mechanistic interpretations are factually correct and free from fabrication or plagiarism.

2. Permitted Uses
JIBR permits the use of AI tools strictly for auxiliary tasks, including:
-Language and Readability: Refining grammar, improving scientific phrasing, and translating manuscripts to enhance clarity for an international audience.
-Data Processing and Coding: Assisting with computational biology tasks such as basic bioinformatics scripting (e.g., R/Python pipelines), statistical modeling, and routine data visualization.
-Structural Planning: Brainstorming literature search strategies, organizing structural outlines, or generating preliminary summaries of background research to expedite the writing process.

3. Prohibited Uses
-Core Scientific Content Generation: Authors must not rely on AI to generate foundational intellectual content, including experimental hypotheses, mechanistic explanations of biological pathways (e.g., metabolic cascades, signaling networks), the interpretation of omics datasets, or translational clinical recommendations.
-Image and Figure Manipulation: AI-generated images or heavily AI-modified scientific figures (e.g., western blots, microscopy images, agarose gels, or structural biology renderings) are strictly prohibited, unless the AI-generated imagery itself is the explicit subject of the study (e.g., evaluating AI-predicted protein folding).
- Unverified Citations AI is known to generate fake or incorrect references. Authors are required to manually verify all citations against primary sources. Do not use AI to generate or populate the reference list.

4. Mandatory Disclosure
If AI tools have been utilized for any purpose beyond basic spelling and grammar checks, authors must explicitly disclose this during submission. The disclosure must be placed in a dedicated section titled "Disclosure of AI and AI-Assisted Technologies" immediately preceding the References list.

The disclosure must include:
- The specific name(s) and version(s) of the AI tool(s) used.
- A clear description of the purpose(s) for which the tool was employed (e.g., statistical analysis, language editing, structural modeling).
- A confirmation statement signed off by all authors affirming that they have comprehensively reviewed, fact-checked, and edited all AI-generated outputs and accept total responsibility for the final published content.

5. Reviewer and Editor Guidelines
- Confidentiality and Security: Reviewers are strictly forbidden from uploading any part of a submitted manuscript (including abstracts, text, figures, or tables) into generative AI tools for summarization, evaluation, or language polishing. This act violates the confidentiality of the peer-review process and may compromise unpublished proprietary biological data.
- Integrity and Screening: The editorial office reserves the right to employ AI-detection software and image-forensic tools during the initial screening phase to ensure compliance with JIBR’s stringent standards regarding originality, image integrity, and data authenticity. Manuscripts found in violation of this policy may be desk-rejected or retracted.

 

Funding and Revenue Policy
The Journal of Integrated Biotechnology Research (JIBR) operates as a diamond open-access publication, maintaining a firm commitment to eliminating financial impediments for both contributing authors and end-users. In accordance with this principle, the journal imposes no submission fees, article processing charges (APCs), or any other publication-related levies on manuscript submitters. Concurrently, all published content is made freely and perpetually accessible online without subscription requirements or paywall restrictions, thereby facilitating the unrestricted global dissemination of biotechnological research.
All operational expenditures (encompassing editorial administration, peer-review coordination, copyediting, and digital dissemination) are comprehensively subsidized by Universitas Negeri Surabaya. This institutional support ensures the journal’s financial sustainability while preserving the autonomy and scholarly integrity of its editorial functions.
To maintain complete fiscal independence, JIBR abstains from all commercial revenue streams, including but not limited to advertising, reprint sales, supplemental issue fees, or paid thematic collections. This non-commercial framework guarantees that all editorial determinations are rendered exclusively on the basis of academic merit, scientific rigor, and thematic pertinence, insulated from any external commercial or financial influence.

This policy underscores JIBR’s unwavering dedication to the principles of open science and the equitable, barrier-free exchange of knowledge within the interdisciplinary field of integrated biotechnology and translational research.

 

Anti-Plagiarism Policy
The Journal of Integrated Biotechnology Research (JIBR) upholds the highest standards of scholarly integrity and accepts only original, unpublished work. All manuscripts submitted to the journal must constitute the authors' own intellectual contributions and be entirely free from plagiarism, fabrication, or any form of textual or data misappropriation. Furthermore, submissions must not have been previously published, nor be concurrently under consideration for review or publication by any other journal, conference, or publishing platform.
The authors bear full and exclusive responsibility for the originality and authenticity of their submitted work. To safeguard the journal's academic rigor, all incoming manuscripts are subjected to a mandatory similarity-checking process using established detection software, including Turnitin and/or iThenticate. Manuscripts that exhibit an unacceptably high level of textual overlap or other forms of plagiarism will be summarily rejected without further review, and may result in additional editorial action in accordance with COPE guidelines.